VITAMIN D3 HEVERT Tablets, 200 pcs

Instructions for use for VITAMIN D3 HEVERT Tablets, 200 pcs

Detailed instructions for VITAMIN D3 HEVERT Tablets, 200 pcs

Field of use

• For prevention in the event of recognizable risk of vitamin D deficiency in the case of otherwise healthy without absorption disorder (disruption of vitamin D in the intestine).
• For supporting osteoporosis.
• For prevention against rickets.
• For prevention against rickets in premature babies.

Mode of action

Vitamin D3 Hevert Tablets (package size: 200 pc) supply the body with the vitamin D. Vitamin D important for many functions wears to maintain normal bones and teeth and a normal muscle function. In addition, it has a function in cell division, wears for a normal function of the immune system, normal intake and use of calcium and phosphorus and thus a normal calcium level in the blood.

Active ingredients / ingredients / ingredients

0.025 mg Colecalciferol
1000 Ie Colecalciferol
Butylhydroxytoluol HILDUFT (+)
Calcium hydrogen phosphate 2-water auxiliary material (+)
Cellulose, microcrystalline auxiliary material (+)
Crospovidon auxiliary material (+)
Gelatine auxiliary substance (+)
Magnesium stair auxiliary material (+)
Sodium aluminum silicat auxiliary substance (+)
Povidon K25 Hedge substance (+)
Saccharosis auxiliary substance (+)
Silicium dioxide, high disperser auxiliary substance (+)
Strength, modified auxiliary substances (+)
Triglyceride, medium -chain auxiliary material (+)

Contradictions

• When are you not allowed to take vitamin D3?
  • Vitamin D3 must not be used in the event of hypersensitivity (allergy) compared to Colecalciferol (vitamin D3) or one of the other components.
  • In the case of hypercalcemia (increased calcium concentration in the blood) and/or hypercalciuria (increased calcium concentration in urine), vitamin D3 must not be taken.
  • Vitamin D3 should not be taken in pseudohypoparathyroidism (disturbance of the parathormone household), since the vitamin D requirement can be reduced by the phases of normal vitamin D sensitivity, with the risk of long overdose. For this purpose, more controllable active ingredients with vitamin D activity are available.

dosage

• The following information applies unless your doctor prescribed the preparation.
• Please adhere to the application regulations, otherwise the preparation cannot work properly.
  • For prevention in the event of recognizable risk of vitamin D deficiency in the case of otherwise healthy without absorption disorders, ½ tablet (corresponding to 0.0125 mg or 500 i.e. vitamin D).
  • 1 Tablet daily for supporting osteoporosis (corresponding to 0.025 mg or 1000 i.E. vitamin D).
  • ½ Tablet daily (corresponding to 0.0125 mg or 500 i.e. vitamin D).
  • The dosage must be determined by the treating doctor. In general, 1 tablet (corresponding to 0.025 mg or 1000 i.e. vitamin D) are recommended for prevention against rickets in premature babies.
• During long -term treatment, the calcium levels in the blood and urine should be monitored regularly and the kidney function should be checked by measuring the serum creatinine. If necessary, a dose adjustment must be made according to the blood calcium values.

• Duration of the application
  • Please ask your doctor about the necessary duration of the application.

• Overdose and other application errors
  • Taking an excessive amount
  • Symptoms of an overdose
    • Ergocalciferol (vitamin D2) and Colecalciferol (vitamin D3) only have a relatively low therapeutic width. In adults with a normal function of the parathyroid glands, the threshold for vitamin D intoxications is Zwipe 40,000 and 100,000 I.E. a day over 1 to 2 months.
    • Infants and toddlers can react sensitively to far lower doses. Therefore, warnings are carried out without medical control before the supply of vitamin D.
    • In the case of overdose, there is an increase in phosphorus in the blood and urine to the hypercalcalcemia syndrome (increased calcium concentration in the blood), later also to calcium deposits in the tissues and especially in the kidney (kidney stones and kidney calcification) and vessels.
    • The symptoms of intoxication are not very characteristic and express themselves in nausea, vomiting, initially often diarrhea, later constipation (constipation), loss of appetite, weary, head, muscle and joint pain, muscle weakness as well as stubborn sleepiness, azotemia (increased nitrogen concentration in the blood), Increased thirst and increased urge to urinate and drying out in the final phase.
    • Typical laboratory findings are hypercalcemia (increased calcium concentration in the blood), hypercalcuria (increased calcium concentration in urine) and increased serum values for 25 hydroxycalciferol.
  • Therapy measures for overdose
    • In the case of overdose, measures to treat the often long -term and possibly threatening hypercalcemia (increased calcium concentration in the blood) are required.
    • The first measure is the vitamin D preparation; A normalization of hypercalcemia (increased calcium concentration in the blood) as a result of vitamin D intoxication takes several weeks.
    • Restrained according to the extent of hypercalcemia (increased calcium concentration in the blood), calcium -free diet or calcium -free diet, plenty of fluid intake, increase in urine excretion by means of the medicine furosemide and the administration of glucocorticoids (medicines for the treatment of certain allergic diseases) and calcitonin (hormone Calcium concentration in the blood).
    • In the case of sufficient kidney function, infusions with isotonic saline (3 - 6 l in 24 hours) with the addition of furosemide (medicinal products to increase urine excretion) as well as 15 mg/kg kg/h. Sodium defeat (medicinal products that binds calcium in the blood) under continuous calcium and EKG control quite reliably reducing calcium-lowering. In the event of reduced urinary excretion, on the other hand, hemodialysis treatment (blood wash) with a calcium-free dialysate is indicated.
    • There is no special antidote. Please ask your doctor about the symptoms of an overdose of vitamin D.

• Taking an insufficient amount or intake was forgotten
  • If you have taken too little of the preparation or have forgotten an intake, please do not take double drugs next time, but continue taking it as intended.

• Evering was canceled or interrupted
  • In the event of an interruption or early end of the treatment, your symptoms can deteriorate or reappear. Please ask your doctor.

• If you have any further questions about the application of the drug, ask your doctor or pharmacist.

Taking

• The tablets should be taken with sufficient liquid.
• In infants and toddlers, you should let the tablet disassemble on a teaspoon with water and put the dissolved tablet in your mouth directly, preferably during a meal.
• Addition of the crumbled tablets to a bottle or bleeding period for infants is not recommended, since no complete intake can be guaranteed. If the tablets are still to be administered in the food, the addition will only be brought to the boil. When using vitaminized food, the amount of vitamin D contained therein must be taken into account.

Patient information

• Prevention measures for the application
  • The following describes when you can only use the preparation under certain conditions and only with special caution. Ask your doctor. This also applies if this information has been on your own.
  • With inclination for education calcium -containing kidney stones should not be taken vitamin D3.
  • In patients with disturbed excretion of calcium and phosphate via the kidney, when treating benzothiadiazin derivatives (medicines for promoting urine excretion) and for immobilized patients, vitamin D3 should only be used with special caution, since the risk of hypercalcemia (increased calcium concentration in the blood should be used ) and hypercalciuria (increased calcium concentration in the urine). The calcium levels in the blood and urine should be monitored in these patients.
  • During long -term treatment with vitamin D3, the calcium levels in the blood and urine should be monitored and the kidney function should be checked by measuring the serum creatinine.
  • This review is particularly important in older patients and at the same time treatment with heart glycosides (medicines to promote the function of the cardiac muscles) or diuretics (medicines to promote urine excretion). In the case of hypercalcemia (increased calcium concentration in the blood) or signs of reduced kidney function, the dose must be reduced or the treatment is interrupted. It is advisable to reduce the dose or to interrupt the treatment if the calcium content in the urine is 7.5 mmol/24 hours (300 mg/24 hours).
  • If other vitamin D-containing medicines are prescribed, the dose of vitamin D must be taken into account in this preparation. Additional administration of vitamin D or calcium should only be carried out under medical monitoring. In such cases, the calcium levels in the blood and urine must be monitored.
  • In patients who suffer from sarcoidosis, vitamin D3 should only be used with caution, since the risk of increased conversion of vitamin D into its active form insists. The calcium levels in the blood and urine should be monitored in these patients.
  • In patients with restricted kidney function that are treated with vitamin D3, the effect on the calcium and phosphate balance should be monitored.
• Infants and toddlers
  • The preparation should be used particularly carefully in infants and toddlers, since they may not be able to swallow and suffocate the tablets. It is recommended to dissolve the tablets as stated instead.

• Wateriness and operating machines
  • There are no special precautions required.

Pregnancy

• During pregnancy, the preparation should only be taken after a strict indication and only dosed as it is absolutely necessary to fix the defect. Overdoses of vitamin D during pregnancy must be prevented because long-lasting hypercalcemia (increased calcium concentration in the blood) can lead to physical and intellectual disabilities as well as innate heart and eye diseases of the child.
• Vitamin D and its metabolic products pass into breast milk. An overdose in the infant generated in this way has not been observed.

Hints

Search terms: Fatigue drive weakness listlessness fatigue keptic tiredness medium osteoporosis treatment osteomalacia osteopathy bone breakdown soft bone softening Skeletonal deformation stable bone loss bone bone growth vitamin-d3 preparation summer sun hormone occur information food bleating